CDNA

70.0002.67%
JM

Jessica Meng

Chief Commercial Officer

Ms. Jessica Meng serves as Chief Commercial Officer of CareDx Inc. since September 12, 2024. She served as Chief Commercial Officer at Delfi Diagnostics, Inc. since July 2022. She serves as Chief Commercial Officer at Better Therapeutics, Inc. since February 2024. In her role as Chief Commercial Officer of DELFI Diagnostics, Jessica created and drove a nontraditional go-to-market strategy to gain early adoption of a revolutionary blood screening test for cancer, well ahead of guideline inclusion and broad reimbursement. She previously led the Women's Health Division of Myovant Sciences as General Manager and Vice President of Sales & Marketing, where she played a key role in the formation of the co-promotion partnership with Pfizer. She was Vice President of Marketing at Veracyte, Inc. since January 8, 2018. Ms. Meng came to Veracyte from Genentech where she led marketing for Avastin in oncology. essica spent years in commercial leadership roles of increasing responsibilities at Genentech, most notably leading the marketing of Genentech's blockbuster oncology product, Avastin, to the height of its commercial success in gastrointestinal and gynecological cancers as well as glioblastoma. Jessica holds an MBA in Marketing and Strategic Management from the Wharton School of Business and Bachelor of Science in Finance and Bachelor of Arts in International Relations with a minor in Mathematics from the University of Pennsylvania.

公司職務